A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Antidepressants, such as Prozac, are already used to treat the condition but Canadian and Italian scientists set out to ...

While it is debatable as to exactly which of the many war-mongering lies told by politicians has resulted in the most ...

Chinese actress Zhao Lusi has made her first public appearance following a month-long treatment for depression, capturing ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.